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framework for understanding the molecular basis of ad-George F. Koob,* Pietro Paolo Sanna,
and Floyd E. Bloom diction (Koob and Le Moal, 1997; Koob et al., 1998).
The underlying molecular and cellular changes thatDepartment of Neuropharmacology
The Scripps Research Institute occur with the transition from occasional drug use to
pathological abuse and addiction are only partially un-La Jolla, California 92037
derstood as yet. To reach a more complete understand-
ing, these events will have to be integrated with the
animal models of the different elements of the addictionHuman addictions are chronically relapsing disorders
process, including models of the transition from simplecharacterized by compulsive drug taking, an inability
drug taking to compulsive use at the molecular, cellular,to limit the intake of drugs, and the emergence of a
and behavioral levels. In this review, we will focus inwithdrawal syndrome during cessation of drug taking
particular on the factors that drive drug-seeking behav-(dependence). The developmentof an addiction impacts
ior at different stages of the addiction cycle (Koob andon several separate neurobiological processes, and
Le Moal, 1997), and we will place particular emphasisthese effects are both drug- and drug use±dependent.
on trying to identify what is currently known and whatIn animal models of addiction, changes in specific neu-
remains to be elucidated.rotransmitter systems within a highly limited band of
structures, including specific parts of the nucleus ac-
cumbens and amygdala, may underlie drug reward and Neurobiological Substrates for the Acute
the motivational effects associated with dependence. Reinforcing Effects of Drugs of Abuse
Changes in the signals mediated by several neurotrans- Animals and humans will readily self-administer the
mitters, including dopamine, opioid peptides, and corti- same classes of drugs, and such self-administration
cotropin-releasing factor (CRF), and in the regulation of defines these drugs as positive reinforcers (Headlee et
selected transcription factors within the neurons of this al., 1955). The powerful reinforcing properties of such
reward circuit, may underlie the vulnerability to relapse drugs are revealed by the efforts experimental animals
that characterizes addiction in humans. will perform to get them, such as pressing a lever multi-
ple times to receive an intravenous injection of the drug.
While early work focused on drug-taking behaviors inAnimal Models of Addiction
dependent animals (largely primates), subsequent stud-Addiction, also known as substance dependence (Amer-
ies have replicated the same behaviors in nondepen-ican Psychiatric Association, 1994), is a chronically re-
dent animals (largely rodents) (Schuster and Thompson,lapsing disorder that is characterized by three major
1969). Since rodents are more tractable experimentally,elements: (1) compulsion to seek and take the drug, (2)
they have provided much recent insight into the perti-loss of control in limiting intake, and (3) emergence of
nent circuits and transductive mechanisms for the acutea negative emotional state (e.g., dysphoria, anxiety, irri-
reinforcing effects of drugs of abuse (Koob and Bloom,tability) when access to the drug is prevented (defined
1988).here as dependence) (Koob and Le Moal, 1997). Both
Neuropharmacological studies have established anclinically and in experimental animals, the occasional
important role for the dopaminergic system in the acuteuse of an abusable drug is distinct from repeated drug
reinforcing effects of cocaine (see Table 1) (Woolvertonuse and the emergence of chronic drug addiction. The
and Johnson, 1992). The midbrain dopamine system isgoal of current neuroscience research is to understand
composed of two major projections: the nigrostriatalthe cellular and molecular mechanisms that mediate the
system, which projects from the substantia nigra to thetransition between occasional, controlled drug use and
corpus striatum, and the mesocorticolimbic dopaminethe loss of behavioral control over drug seeking and
system, which projects from the ventral tegmental areadrug taking that defines chronic addiction (Koob and Le
(VTA) to the nucleus accumbens, olfactory tubercle,Moal, 1997).
frontal cortex, and amygdala. It is the mesocorticolimbicMuch of the recent progress in understanding the
system that hasbeen primarily implicated in the reinforc-mechanisms of addiction has derived from the develop-
ing actions of drugs of abuse. Psychostimulants suchment of animal models of addiction on specific drugs
as cocaine and d-amphetamine elevate extracellular do-such as opiates, stimulants, and ethanol. These animal
pamine by inhibiting reuptake of dopamine by the dopa-models have localized the synaptic sites and transduc-
mine transporter and, in the case of d-amphetamine,tive mechanisms in the nervous system on which drugs
also by promoting reverse transport of dopamine. Dur-of abuse act initially and are beginning to be used to
ing intravenous cocaine self-administration, increasedexplore how the nervous system adapts to drug use.
extracellular dopamine can be detected in the nucleusWhile no animal model of addiction fully emulates the
accumbens using in vivo microdialysis (Pettit and Jus-human condition, animal models do permit investigation
tice, 1989). In addition, selective destruction of meso-of elements of the process of drug addiction, and the
corticolimbic dopamine neurons with the neurotoxindata derived from these models provides an empirical
6-hydroxydopamine (6-OHDA) eliminates cocaine self-
administration; similar decreases in cocaine self-admin-
istration occur when 6-OHDA lesions are restricted to*To whom correspondence should be addressed.
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and stereotypy (Giros et al., 1996). However, such dopa-Table 1. Neurobiological Substrates for the Acute Reinforcing
mine transporter±deficient mice still could be trained toEffects of Drugs of Abuse
self-administer cocaine despite persistently high levels
Drug of Abuse Neurotransmitter Sites
of extracellular dopamine in dopaminergic terminal
Cocaine and Dopamine Nucleus accumbens fields, suggesting a more complex basis for the psycho-
amphetamines Serotonin Amygdala stimulant reinforcement (Rocha et al., 1998). Besides
Opiates Dopamine Ventral tegmental area inhibiting the dopamine transporter, psychostimulants
Opioid peptides Nucleus accumbens
also inhibit the reuptake of serotonin and noradrenaline,Nicotine Dopamine Ventral tegmental area
which may contribute to their reinforcing actions possi-Opioid peptides? Nucleus accumbens
Amygdala? bly in part by modulating dopamine neurotransmission
THC Dopamine Ventral tegmental area (Parsons et al., 1995; Tanda et al., 1997b).
Opioid peptides? Much like psychostimulants, opiate drugs are readily
Ethanol Dopamine Ventral tegmental area self-administered intravenously by animals, and the sys-
Opioid peptides Nucleus accumbens
temic and central administration of competitive opiateSerotonin Amygdala
antagonists will decrease opiate reinforcement (re-GABA
Glutamate viewed by Koob and Bloom, 1988; Di Chiara and North,
1992). The reinforcing actions of opiates appear to be
largely mediated by the m opioid receptor since selective
the dopamine fibers of the region of the nucleus accum- m antagonists decrease opioid reinforcement in a dose-
bens (Roberts et al., 1980). Multiple receptor subtypes dependent manner (Negus et al., 1993). In addition, mor-
exist for transducing the increase in extracellular dopa- phine reinforcement is abolished in mice with a targeted
mine induced by psychomotor stimulants into behav- disruption of the m opioid receptor gene (Matthes et al.,
ioral action. Antagonists for the dopamine D1, D2, and 1996).
D3 receptor subtypes all decrease the reinforcing prop- The reinforcing properties of opiates utilize the same
erties of cocaine (Woolverton and Johnson, 1992; Caine circuitry implicated in the actions of cocaine and am-
et al., 1995; Koob and Le Moal, 1997; Epping-Jordan et
phetamine stimulants but may involve additional sites
al., 1998a).
of interaction (Koob and Bloom, 1988) (Table 1). Block-
The neuronal interaction responsible for cocaine rein-
ade of opioid receptors either in the VTA or the nucleus
forcement and the motivation to seek the drug appears
accumbens will decrease heroin self-administration.
to reside within the nucleus accumbens (Chang et al.,
Furthermore, rats will lever press to administer opioid
1994; Carelli and Deadwyler, 1996; Peoples et al., 1997).
peptides in their nucleus accumbens or VTA, and opiate
Electrophysiological recordings in animals receiving in-
administration into these restricted brain regions will
travenous cocaine by self-administration have identified
reinforce drug-seeking behavior (reviewed by Di Chiaraseveral patterns of neuronal responses in the nucleus
and North, 1992; Shippenberg et al., 1992). Opiates, likeaccumbens, all time-locked to the self-administered
other drugs of abuse, increase dopamine release in thedrug infusion. One group of neurons fires just before
nucleus accumbens (Di Chiara and Imperato, 1988; Pon-the lever press, and this anticipatory response may be
tieri et al., 1995) (see below). However, the reinforcingan initiation or trigger mechanism. A second group of
effect of opiates in the nucleus accumbens persistsneurons appears to change firing rate only after the
when all dopamine projections there are destroyed, sug-cocaine infusion, and these neurons may represent the
gesting that their reinforcing actions may involve bothdirect effects of reinforcement (Carelli and Deadwyler,
a dopamine-dependent (VTA) and a dopamine-inde-1996). Other neurons fire in proportion to the interinfu-
pendent (nucleus accumbens) mechanism (Koob andsion interval between consecutive self-administration
Bloom, 1988).responses (Peoples and West, 1996). However, there
Sedative-hypnotics, including ethanol, are thought toappears to be a fourth type of neuronal firing pattern
produce their reinforcing actions through multiple neu-unique to cocaine self-administration; these ªcocaine-
rotransmitter systems (Engel et al., 1992) (Table 1). Onespecific cellsº fire both before and after the cocaine-
of the major sites proposed for ethanol reinforcementreinforced response (Carelli and Deadwyler, 1996). Even
is modulation of GABA receptors (Liljequist and Engel,more intriguing is the observation that this subset of
1982; Samson and Harris, 1992). GABA antagonists re-neurons also fires to sensory stimuli (sounds or lights)
verse many of the behavioral effects of ethanol (Liljequistthat have been experimentally paired with cocaine deliv-
and Engel, 1982; Samson and Harris, 1992). Further-ery. Nucleus accumbens neurons may thereforemediate
more, the benzodiazepine R0 15±4513 (termed an in-conditioned drug responses (Carelli and Deadwyler,
verse agonist because it produces effects opposite to1996). Similarly, conditioned sensory stimuli are strong
those of typical benzodiazepines) will reverse some ofelicitors of ªcravingº in cocaine-taking humans.
the behavioral effects of ethanol, and dose-dependentlyRecent studies using recombinant DNA techniques to
reduces oral ethanol self-administration in rats (Samsonªknock outº specific genes involved in dopaminergic
and Harris, 1992). When potent GABA antagonists areneurotransmission may provide evidence of some re-
microinjected into the brain, the most effective site todundancy in the neurochemical basis of cocaine rein-
reduce ethanol consumption is the central nucleus offorcement. In a mouse strain in which the gene for the
the amygdala (Hyttia and Koob, 1995).dopamine transporter was disrupted by homologous re-
Ethanol reinforcement also appears to involve activa-combination, psychostimulants failed to alter baseline
tion of brain dopamine systems. Acutely, ethanol con-extracellular dopamine levels and failed to induce be-
havioral effects such as enhanced locomotor activity sumption or systemic injection reduces the firing rate
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of pars reticulata GABA neurons, which are thought to Table 2. Drug Effects on Thresholds for Rewarding Brain
exert an inhibitory control over VTA dopaminergic neu- Stimulation
rons (Diana et al., 1993; Merue and Gessa, 1985), and
Withdrawal
increases concentrations of dopamine in the extracellu- Acute from Chronic
lar compartment in the nucleus accumbens. Dopamine Drug Class Administration Treatment
receptor antagonists injected into the nucleus accum-
Psychostimulants ↓ ↑bens reduce lever pressing for ethanol in nondependent
(cocaine, amphetamines)
rats, and basal extracellular dopamine levels are in- Opiates ↓ ↑
creased in ratschronically consuming low doses of etha- (morphine, heroin)
Nicotine ↓ ↑nol (reviewed by Koob et al., 1994b). However, virtually
Sedative-Hypnotics ↓ ↑complete 6-hydroxydopamine denervation of the dopa-
(ethanol)mine inputs to the nucleus accumbens fails to alter vol-
THC ↓ ↑untary responding for ethanol, suggesting that nucleus
accumbens dopamine transmission may not be critical
for reinforcing actions of ethanol (Koob et al., 1994b).
dopamine system (Chen et al., 1991), and recent dataMoreover, manipulations that change brain serotonin
suggest that THC can selectively increase the releasesynaptic availability can decrease ethanol intake (Sellers
of dopamine in the shell of the nucleus accumbens simi-et al., 1992). For example, serotonin reuptake blockers
lar to other drugs of abuse (Tanda et al., 1997a).decrease ethanol intake but so do antagonists of the
serotonin-3 and serotonin-2c receptors, suggesting a
Negative Reinforcement Associated with Addictioncomplex interaction of serotonin function and ethanol
Repeated drug use is thought to arise from the neuro-reinforcement (LeMarquand et al., 1994).
chemical actions causing the positive reinforcing effectsOpiate antagonists also reduce ethanol self-adminis-
of a drug. However, the transition from occasional drugtration in several animal models (Tabakoff and Hoffman,
use to drug addiction has been thought to require an1996). The central nucleus of the amygdala is particularly
additional source of reinforcement, the reduction of thesensitive to this opioid antagonism of oral ethanol self-
aversive (negative) emotional state arising from re-administration (Heyser, Roberts, and G. F. K., unpub-
peated use. Here, drug taking presumably removes thelished data). Double-blind, placebo-controlled clinical
dysphoria, anxiety, irritability, and other unpleasant feel-trials showed that naltrexone can significantly reduce
ings produced by drug abstinence. Other somatic physi-human ethanol consumption, frequency of relapse, and
cal signs, such as tremor, temperature changes, andªcravingº for ethanol in detoxifiedalcoholics, suggesting
sweating, which also reflect the state of dependence,that the motivation to resume ethanol use may involve
presumably have little if any motivating properties onopioid systems (Volpicelli et al., 1992). Finally, low doses
drug use (Koob, 1996; Koob and Le Moal, 1997). Indeed,of ethanol will sensitively inhibit the NMDA subtype of
one of the defining features of drug addiction is thoughtglutamate receptors; in drug discrimination studies, ani-
to be the establishment of such a negative emotionalmals substitute glutamate antagonists for ethanol (Ta-
state (Russell, 1976). Consistent with this hypothesis,bakoff and Hoffman, 1996).
all major drugs of abuse have been found to produce aIntravenous self-administration of nicotine is also
negative emotional state in dependent humans duringblocked by dopamine antagonists and dopamine-selec-
acute abstinence. The combination of the positive rein-tive lesions of the nucleus accumbens (Corrigall et al.,
forcing effects of the drugs with reduction of the nega-1992; Dani and Heinemann, 1996). Nicotine withdrawal
tive emotional states of drug abstinence providesa pow-can also be produced by opioid antagonists (Dani and
erful motivational force for the compulsive drug takingHeinemann, 1996). Nicotine thus may activate both the
that characterizes addiction.dopamine system and some opioid peptide neurons in
One likely mechanism for this negative emotionalstatethe same neural circuitry associated with other drugs
may be a reduction in brain reward function. In studiesof abuse (Corrigall et al., 1992) (see Table 1). Exactly
employing intracranial self-stimulation behavior, to di-which type of nicotinic receptor subunit configuration
rectly study brain reward circuits, animals that havemediates the reinforcing effects of nicotine is not clear,
been made chronically dependent show increased re-but neurons in the VTA and nucleus accumbens express
ward thresholds (i.e., decreased reward) during with-high levels of the a6, a2, and a3 subunits (Le Novere et
drawal (reviewed by Koob et al., 1993; Koob, 1996; Koobal., 1996).
and Le Moal, 1997). These decreases in reward haveTetrahydrocannabinol (THC) shares effects in animal
been observed following the withdrawal from psycho-models of drug reinforcement similar to those of other
motor stimulants, opiates, ethanol, THC, and nicotinedrugs of abuse (Anthony et al., 1994). Upon acute admin-
and are dose related to the amount of drug that hadistration, THC decreases reward thresholds in rats
been administered before withdrawal (Epping-Jordan et(Gardner et al., 1988; Lepore et al., 1996), produces a
al., 1998b; Gardner and Vorel, 1998) (Table 2).place preference in rats (Lepore et al., 1995), and, as a
synthetic THC analog, is intravenously self-administered
Common Neuropharmacological Elementsin mice (Fratta et al., 1997, Soc. Neurosci., abstract).
in AddictionTHC binds to the cannabinoid-1 receptor, which is
The molecular and cellular basis for these changes inwidely distributed throughout the brain but particularly
motivation to take drugs may reside in the neuroadapta-in the extrapyramidal motor system of the rat (Herken-
ham et al., 1990). THC activates the mesocorticolimbic tions arising in the same neural elements that mediate
Neuron
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Microinjections into the central nucleus of the amygdalaTable 3. Neurotransmitters Implicated in the Motivational
of lower doses of a CRF antagonist also reversed theEffects of Withdrawal from Drugs of Abuse
anxiogenic-like effects of ethanol withdrawal. Similar↓ Dopamine
doses of the CRF antagonist injected into the amygdala↓ Opioid peptides
reversed the aversive effects of opiate withdrawal↓ Serotonin
(Koob, 1996). In vivo microdialysis studies have shown↓ GABA
↑ Corticotropin-releasing factor an increase in extracellular CRF during ethanol, cocaine,
and THC withdrawal (Merlo-Pich et al., 1995; Rodriguez
de Fonseca et al., 1997; Richter and Weiss, personal
the acute reinforcing actions of these drugs. Earlier work communication). Thus, CRF activation may be a com-
suggested that these adaptations occur both within the mon element in the development of drug dependence
drug-sensitive reinforcement system and in additional and may contribute to motivational effects involving
systems outside the drug-sensitive reward system (Koob such subjective symptoms as increased stress and neg-
and Bloom, 1988). Several common elements have been ative affect (Koob, 1996).
identified that appear to change with chronic drug ad- The neurochemical changes highlighted above illus-
ministration and could underlie (or mediate) the compul- trate neuroadaptations common to all drugs of abuse
sive self-administration of all drugs (Koob, 1992; Koob, (Koob, 1996). However, even more intriguing is the pos-
1996; Koob and Le Moal, 1997) (Table 3). sibility that a neuroanatomical entity termed the ex-
Functional changes in the mesolimbic dopamine sys- tended amygdala (Heimer and Alheid, 1991) (Figure 1)
tem appear to be common to the chronic actions of all mayrepresent a common anatomicalsubstrate for acute
drugs of abuse (Nestler, 1996). Drug discontinuation is drug reward and the negative effects of compulsive drug
accompanied by biochemical and electrophysiological administration on reward function. The extended amyg-
evidence of decreases in dopamine function (Diana et dala is comprised of the medial subregion of the nucleus
al., 1993; Nestler, 1996; Weiss et al., 1996). During with- accumbens (termed the shell of the nucleus accum-
drawal from chronic ethanol administration, there is a bens), the bed nucleus of the stria terminalis, and the
decrease in extracellular dopamine in the nucleus ac- central nucleus of the amygdala (Heimer and Alheid,
cumbens, and, concomitantly, neurons of the mesolim- 1991). Heimer has noted that all of these regions share
bic dopamine system show dramatic reductions in certain cytoarchitectural and circuitry similarities (Heimer
spontaneous firing rates and patterns but not in the and Alheid, 1991). The extended amygdala receives nu-
number of spontaneously active neurons (Diana et al., merous afferents from limbic structures, such as the
1993; Weiss et al.,1996). These biochemical and electro- basolateral amygdala and hippocampus, and sends not
physiological changes can be reversed by ethanol ad- only efferents to the medial part of the ventral pallidum
ministration. Another neurotransmitter system impli- but also a large projection to the lateral hypothalamus,
cated in the acute reinforcing actions of drugs of abuse thus further defining the specific brain areas that inter-
whose function is altered during the development of face classical limbic (emotional) structures with the ex-
dependence is the opioid peptide system, as seen with trapyramidal motor system.
either chronic opiate usage (Self and Nestler, 1995; Nest- The structures comprising the extended amygdala
ler, 1996) or with other drugs of abuse (Di Chiara and may further define the neural substrates for the acute
North, 1992). Here, the functional changes are manifest reinforcing actions of drugs of abuse (Koob, 1992; Koob,
by a dramatic increased sensitivity to opioid receptor 1996). Acute administration of all the major drugs of
antagonists, probably mediated by alterations in opioid abuse produces increases in extracellular levels of do-
receptor signal transduction (see below) (Nestler, 1996; pamine in the shell of the nucleus accumbens (Pontieri
Widnell et al., 1996). et al., 1995). The ventromedial shell of the nucleus also
In addition, several neurotransmitter systems that are expresses high levels of the dopamine D3 receptor
not involved in the acute reinforcing effects of drugs of mRNA (Diaz et al., 1995), and the shell of the nucleus
abuse do appear to become involved following chronic accumbens is particularly sensitive to the cocaine an-
drug administration. These include several neuropep- tagonist activity of a dopamine D1 antagonist (Caine et
tides, notably dynorphin, neuropeptide FF (NPFF), and al., 1995). The central nucleus of the amygdala also has
CRF. Neurons containing the opioid peptide dynorphin a role in ethanol reinforcement. Microinjection of GABA
in the nucleus accumbens appear to be functionally antagonists or opioid peptide antagonists into the cen-
activated following chronic administration of cocaine tral nucleus can attenuate lever pressing for oral ethanol
(Hyman, 1996), while anti-opioid neuropeptides such as (Hyttia and Koob, 1995; Heyser, Roberts, and G. F. K.,
NPFF may be activated following chronic opiates (Malin unpublished data). Perhaps more intriguing is recent
et al., 1990; Lake et al., 1992). evidence that the extended amygdala may be an impor-
CRF, with its many actions on hormonal and behav- tant substrate for the changes in the reward system
ioral responses to stressors, may be a brain system en- associated with dependence. In animals dependent on
gaged during drug dependence by all drugs of abuse. ethanol, microinjections of previously ineffective doses
Activation of the pituitary adrenal axis long has been of a GABA agonist into the central nucleus of the amyg-
recognized as a characteristic of drug dependence and dala decreased ethanol self-administration (Roberts et
withdrawal in humans (Kreek, 1987). Rats treated re- al., 1996), suggesting that the GABAergic system has
peatedly with cocaine, nicotine,and ethanolshow signif- been altered to become more responsive to agonists
icant anxiogenic-like responses following cessation of during thecourse of dependence. Thus, thesame neuro-
chronic drug administration that are reversed with intra- chemical components in the extended amygdala in-
volved in acute drug actions may become compromisedcerebroventricular administration of a CRF antagonist.
Review
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Figure 1. Horizontal Section of a Rat Brain Depicting the Principal Structures of the Extended Amygdala
These structures include the central nucleus of the amygdala, the shell part of the nucleus accumbens, and the bed nucleus of the stria
terminalis. The drugs listed below each structure refer to potential sites of action of drug reinforcement during the addiction cycle, either
positive or negative. Redrawn with permission from Heimer and Alheid (1991).
during the development of dependence. One may spec- and Nestler, 1995; Hyman, 1996) (see Figure 3). An im-
portant role for the D1 receptor±cAMP±CREB pathwayulate that additional neurochemical systems also may
be engaged within the neurocircuitry of the extended in the neuroadaptation to chronic drug dependencies
is supported also by the recent evidence of effectiveamygdala (Koob and Bloom, 1988), in an attempt to
overcome the chronic presence of the perturbing drug anti-cocaine actions from dopamine D1 antagonists and
effective anti-cocaine priming effects from D1 agonistsand to restore normal function despite the presence of
drug. The changes in CRF on the central nucleus of (i.e., ability of cocaine to reinstate responding in rats
that have stopped responding after cocaine has beenthe amygdala observed in dependent animals during
replaced by saline) (Self et al., 1996). Activation of Giwithdrawal support this hypothesis (Koob et al., 1994a,
proteins, linked to D2 receptors, also appears to be1994b) (see Table 1, Table 2, and Figure 1).
involved in the acute effects of cocaine since pertussis
toxin, which inactivates Gi proteins, produces a dopa-
Molecular, Cellular, and System Adaptations mine receptor antagonist-like effect on cocaine self-
Associated with Brain Motivational Systems administration (Self et al., 1994).
In addition to the changes in neurochemical systems In the VTA, repeated administration of cocaine pro-
that are common to the chronic administration of drugs duces transient decreases in Gi proteins that may lead
of abuse, there are molecular changes that may provide to D2 receptor subsensitivity (Nestler, 1994; Self and
not only the mechanism for the above neurochemical Nestler, 1995). More prolonged effects that persist up
changes butalso the substrate for prolonged adaptation to one month in the nucleus accumbens include a super-
to chronic drug administration. Differences in adaptive sensitivity to D1-mediated responses (Henry and White,
responses at the molecular level may account for indi- 1991), increased levels of adenylyl cyclase and protein
vidual differences in vulnerability to dependence to dif- kinase A (PKA), decreased levels of Gi proteins (Self
ferent drugs. The challenge for future research is to link and Nestler, 1995; Nestler, 1996), and a decrease in the
these changes in plasticity to motivational actions of ability of cocaine to induce the immediate-early gene
dependence (Figure 2). c-fos, followed by the sustained expression of AP-1
Several molecular consequences of motivationally im- transcription factor complexes with altered composition
portant adaptations to chronic cocaine or amphetamine (see below).
administration have been identified. For example, acti- Chronic administration of cocaine also decreases the
vation of D1-like receptors stimulates a cascade of levels of neurofilament proteins in the VTA (Self and
events, including activation of Gs proteins and increased Nestler, 1995). Lower levels of neurofilament proteins
intracellular cyclic AMP formation that ultimately may are associated with decreased axonal transport, and
lead to phosphorylation of transcription factors such as this could decrease the amount of tyrosine hydroxylase
cyclic AMP response element±binding protein (CREB) transported from the VTA to the dopamine nerve termi-
nals in the nucleus accumbens (Self and Nestler, 1995).and to the induction of immediate-early genes (see Self
Neuron
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Figure 2. Schematic Diagram Showing the
Relationship between Different Levels of
Analysis in the Study of Addiction and the
Role of Neuroadaptive Processes
Neuroadaptive mechanisms have been hy-
pothesized to contribute to compulsive be-
havior and addiction by acting at different
levels of the spiraling cycle of the develop-
ment of dependence (Koob and Le Moal,
1997). Both sensitization and counteradapta-
tion may contribute to changes in hedonic
responsiveness and set-points.
Such changes could be responsible for short-term re- Chronic ethanol exposurehas been shown to compro-
mise dopamine and GABAergic systems that are linkedductions in extracellular levels of dopamine release dur-
ing drug withdrawal (Weiss et al., 1992), which then to the continued desire to consume ethanol (see above).
At the molecular level, chronic ethanol is associatedcould trigger upregulation of the cyclic AMP system
(Self and Nestler, 1995) (see above). with decreases in the ability of ethanol to potentiate
GABA-stimulated Cl2 flux, decreased expression of theThese adaptations within the mesolimbic dopamine
system, and its receptor systems, not only could change a1 subunitof theGABA complex (Tabakoff and Hoffman,
1996) and other subunits, and increased expression ofthe function of the dopamine system itself but also may
trigger a second major action, namely increased expres- the b subunit (Tabakoff and Hoffman, 1996). Chronic
ethanol also is associated with increases in specificsion of protachykinin and prodynorphin mRNAs. Dynor-
phin peptides in the nucleus accumbens, in turn, may subunits (NR1 and NR2A) of NMDA receptors (Tabakoff
and Hoffman, 1996). The relationship of these moleculardecrease dopamine release via a presynaptic action on
k opioid receptors; k agonists are known to produce changes in ethanol-receptive elements to the motiva-
tional substrates outlined above may ultimately involveaversive effects in rodents and humans (Hyman, 1996).
Thus, chronic administration of psychomotor stimulants changes in the same transduction systems observed
for other drugs of abuse (Figures 2 and 3). A possiblewould induce prodynorphin gene expression in the nu-
cleus accumbens that opposes the effect of cocaine on anatomical substrate for the molecular action of GABA
on motivational aspects of ethanol dependence is thereward.
Chronic opiate administration is associated with lit- amygdala, a brain region considered important in medi-
ating emotional behavior in general. GABAergic neuronstle evidence of changes in opioid peptide activity or
changes in the number of anyof the knownopioid recep- in the central amygdala also have been proposed to
mediate rapid changes in autonomic activity (Sun andtors (but see Mansour et al., 1995; Zadina et al., 1997).
However, there is strong evidence that a dramatic en- Cassell, 1993), and acute ethanol induces expression of
the immediate-early gene c-fos, a marker of neuronalhancement of sensitivity to the aversive effects of opioid
antagonists can occur in brain areas implicated in the activation, in GABAergic neurons in the central amyg-
dala (Morales, Criado, and P. P. S., unpublished data).acute reinforcing effects of opiates (Stinus et al., 1990;
Self and Nestler, 1995; Nestler, 1996). The molecular Adaptation to chronic nicotine administration also
may occur in the same neuronal circuits associated withbasis for this effect may be at the level of signal trans-
duction (see Figures 2 and 3). Acute administration of its initial molecular actions, namely nicotine on nicotinic
acetylcholine receptors located in the brain mesolimbicmorphine decreases adenylate cyclase activity in the
nucleus accumbens, whereas chronic morphine treat- dopamine system. One recent hypothesis seeks to ex-
plain nicotine tolerance and dependence on the basisment is associated with increases in second messenger
systems, including adenylate cyclase activity and PKA of a prolonged stability in the desensitized state of the
nicotinic acetylcholine receptor following the initial stim-(Nestler, 1996). The hypothesis that these effects con-
tribute to the motivational effects of opiates (e.g., toler- ulation (or ªactivationº) (Dani and Heinemann, 1996).
Consistent with this desensitization hypothesis, long-ance and dependence) is supported by studies showing
that direct administration into the nucleus accumbens term nicotine exposure causes an increase in the actual
number of nicotinic acetylcholine receptors (Collins etof agents that inhibit Gai or activate protein kinase de-
creases the reinforcing effects of opiates (Self et al., al., 1990).
Dani and Heinemann (Dani and Heinemann, 1996)1994). Chronic morphine administration also decreases
the level of the transcription factor CREB in the nucleus have proposed that nicotine stimulates the mesolimbic
dopamine system via activation of nicotinic acetylcho-accumbens. This provides a possible mechanism for
morphine to mediate the alterations in gene expression line receptors to produce the acute reinforcing effects
of nicotine; with continued use, the inactivation of thesethat may underlie the long-term changes in motivational
systems associated with opioid dependence (Widnell et receptors by desensitization would then lead toadaptive
tolerance. Duringabstinence, nicotine levels fall, and theal., 1996) (Figure 3). Genetic disruption of two of the
three types of CREB inmice dramatically reduced symp- increased nicotinic acetylcholine receptors, throughout
the brain, begin to recover to a responsive state thattoms of morphine withdrawal and produced some re-
duction in tolerance to the analgesic effects of morphine may be dependent on the receptor subtype. Engag-
ing nicotinic receptors in non-reward-related pathways(Maldonado et al., 1996).
Review
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Figure 3. Molecular Mechanisms of Neuro-
adaptation
Drugs of abuse, by acting on neurotransmit-
ter systems, affect the phenotypic and func-
tional properties of neurons through the gen-
eral mechanisms outlined in the diagram.
Shown are examples of ligand-gated ion
channels (1) such as the GABAA and the gluta-
mate NMDA receptor (NMR) and G protein±
coupled receptors (R) such as opioid, dopa-
mine (DA), or the cannabinoid CB1 receptors,
among others (2). The latter is activated by
endogenous cannabinoids such as anan-
damide. These receptors modulate the levels
of second messengers like cAMP and Ca21
(3), which in turn regulate the activity of pro-
tein kinase transducers (4). Such protein ki-
nases affect the functions of proteins located
in the cytoplasm, plasma membrane, and nu-
cleus (5±8). Among membrane proteins af-
fected are ligand-gated and voltage-gated
ion channels (6 and 7). Ethanol, for instance,
has been proposed to affect the GABAA re-
sponse via PKC phosphorylation and, at least
in Purkinje cells, via PKA phosphorylation
(Tabakoff and Hoffman, 1996). Gi and Go
proteins also can regulate potassium and cal-
cium channels directly through their bg sub-
units (9). Protein kinase transduction path-
ways also affect the activities of transcription
factors (8). Some of these factors, like CREB,
are regulated posttranslationally by phos-
phorylation; others, like Fos, are regulated
transcriptionally; still others, like Jun, are
regulated both posttranslationally and/or
transcriptionally. While membrane and cyto-
plasmic changes may be only local (e.g., den-
dritic domains or synaptic boutons), changes
in the activity of transcription factors may result in long-term functional changes. These may include changes in gene expression of proteins
involved in signal transduction (10) and/or neurotransmission (11±13), resulting in altered neuronal responses. For example, chronic exposure
to psychostimulants or opiates has been reported to increase levels of PKA (10) and adenylyl cyclase (11) in the nucleus accumbens and to
decrease levels of Gai (11) (Self and Nestler, 1995; Nestler, 1996). Moreover, chronic ethanol induces differential changes in subunit composition
in the GABAA and in the glutamate inotropic receptors (12) and increases expression of voltage-gated calcium channels (VGCC) (13) (Tabakoff
and Hoffman, 1996). Chronic exposure to drugs also alters the expression of transcription factors themselves (14). CREB expression, for
instance, is depressed in the nucleus accumbens and increased in the locus coeruleus by chronic morphine treatment (Nestler, 1996; Widnell
et al., 1996), while chronic cocaine and other chronic treatments induce a transition from Fos induction to the induction of the longer-lasting
Fos-related antigens (FRAs) (reviewed by Hyman, 1996). The receptor systems depicted in the figure may not coexist in the same cells. The
systematic elucidation of their fine distribution and colocalization as well as the definition of the role of pre- and postsynaptic mechanisms
are current and future challenges in the neuroscience of addiction.
could contribute to theaversive emotional states associ- (Aceto et al., 1995). In animals, a withdrawal syndrome
ated with nicotine withdrawal. According to this hypoth- is precipitated by administration of competitive THC
esis, smokers would be, in effect, ultimately medicating antagonists to animals treated chronically with canna-
themselves with nicotine to regulate the number of func- binoids (Aceto et al., 1995), and this precipitated canna-
tional nicotinic acetylcholine receptors (Dani and Heine- binoid withdrawal produced activation of limbic struc-
mann, 1996). Recent work shows that such changes tures as measured by c-fos activation and an increase
may be evident in the a subunit family, with the a4, in extracellular levels of CRF in the central nucleus of
a2, and a7 subunits showing inactivation with chronic the amygdala as seen by other major drugs of abuse
nicotine but the a3 subunit (which is similar in struc- (Rodriguez de Fonseca et al., 1997). Whether chronic
ture to the a6 subunit) showing resistance to desensiti- THC produces cellular and molecular changes in the
zation (Olale et al., 1997). Thus, one could speculate extended amygdala similar to other drugs of abuse will
that there are two powerful forces for development of be a challenge for future research.
nicotine addiction: desensitization of nicotinic receptors
in non-reward pathways (self-medication) and resis-
Craving and Relapsetance to desensitization in reward pathways (positive
Because drug addiction is a chronic relapsing disorder,reinforcement).
the study of vulnerability to relapse is a particularly com-Marijuana is a drug of abuse and addiction in humans,
pelling challenge. However, the biological basis for theand chronic high dose administration of THC or THC
states of craving and protracted abstinence are difficultanalogs produces a dependence syndrome as mea-
sured by behavioral and subjective signs of withdrawal to define. Vulnerability to reinstatement of drug-taking
Neuron
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behavior and ultimately a continuation of compulsive maintenance, withdrawal, and relapse. A particular chal-
drug use presumably reflects some underlying pro- lenge for future studies in the neuroscience of addiction
longed perturbation that emerges long after the with- will be to elucidate the neuroadaptive changes pro-
drawal reactions have subsided. A residual deficit state duced by chronic drug use in animal models of pro-
in the reward system, or sensitization of the reward tracted abstinence and relapse. Presumably, the an-
system to stimuli that predict drug effects, or both, could swers will be found not only in the same molecular and
be responsible for this vulnerability (Koob and Le Moal, cellular elements of the neurochemical systems and
1997) (Figure 2). neurocircuitry responsible for the positive and negative
Animal models of drug craving and relapse continue reinforcement associated with chronic drug use, but
to be developed and refined and are based largely on also in the multiple neuroadaptive mechanisms that es-
conditioned reinforcement where previously neutral tablish long-term memories of the drug rewards (Bailey
stimuli, such as drug injection paraphernalia or specific et al., 1996).
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